INTRODUCTION: The prevalence of cancer survivorship in the USA is expected to increase in the future because the US population is increasing in size and is aging and because survival following diagnosis is improving for many types of cancer. Medical care costs associated with cancer are also projected to increase dramatically. However, currently available data for estimating medical care costs and other important aspects of the burden of cancer, including time spent receiving medical care, productivity loss due to morbidity for patients and their families, and financial hardship, are limited, particularly in the population under the age of 65. METHODS: We describe selected publicly available data sources for estimating the burden of cancer in the USA and a new collaborative effort to improve the quality of these data: the nationally representative Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement. CONCLUSIONS: Data from this effort can be used to address key gaps in cancer survivorship research related to medical care costs, employment patterns, financial hardship, and other aspects of the burden of illness for cancer survivors and their families. IMPLICATIONS FOR CANCER SURVIVORS: Research using the MEPS Experiences with Cancer Survivorship Supplement can inform efforts by health care policy makers, healthcare systems, providers, and employers to improve the cancer survivorship experience in the USA.
INTRODUCTION: The prevalence of cancer survivorship in the USA is expected to increase in the future because the US population is increasing in size and is aging and because survival following diagnosis is improving for many types of cancer. Medical care costs associated with cancer are also projected to increase dramatically. However, currently available data for estimating medical care costs and other important aspects of the burden of cancer, including time spent receiving medical care, productivity loss due to morbidity for patients and their families, and financial hardship, are limited, particularly in the population under the age of 65. METHODS: We describe selected publicly available data sources for estimating the burden of cancer in the USA and a new collaborative effort to improve the quality of these data: the nationally representative Medical Expenditure Panel Survey (MEPS) Experiences with Cancer Survivorship Supplement. CONCLUSIONS: Data from this effort can be used to address key gaps in cancer survivorship research related to medical care costs, employment patterns, financial hardship, and other aspects of the burden of illness for cancer survivors and their families. IMPLICATIONS FOR CANCER SURVIVORS: Research using the MEPS Experiences with Cancer Survivorship Supplement can inform efforts by health care policy makers, healthcare systems, providers, and employers to improve the cancer survivorship experience in the USA.
Authors: K Robin Yabroff; William W Davis; Elizabeth B Lamont; Angela Fahey; Marie Topor; Martin L Brown; Joan L Warren Journal: J Natl Cancer Inst Date: 2007-01-03 Impact factor: 13.506
Authors: Eric A Finkelstein; Florence K Tangka; Justin G Trogdon; Susan A Sabatino; Lisa C Richardson Journal: Am J Manag Care Date: 2009-11 Impact factor: 2.229
Authors: T J Smith; L Penberthy; C E Desch; M Whittemore; C Newschaffer; B E Hillner; D McClish; S M Retchin Journal: Lung Cancer Date: 1995-12 Impact factor: 5.705
Authors: Emily Dowling; K Robin Yabroff; Angela Mariotto; Timothy McNeel; Christopher Zeruto; Dennis Buckman Journal: Cancer Date: 2010-08-01 Impact factor: 6.860
Authors: K Robin Yabroff; Elizabeth B Lamont; Angela Mariotto; Joan L Warren; Marie Topor; Angela Meekins; Martin L Brown Journal: J Natl Cancer Inst Date: 2008-04-29 Impact factor: 13.506
Authors: Gery P Guy; Donatus U Ekwueme; K Robin Yabroff; Emily C Dowling; Chunyu Li; Juan L Rodriguez; Janet S de Moor; Katherine S Virgo Journal: J Clin Oncol Date: 2013-09-16 Impact factor: 44.544
Authors: Whitney E Zahnd; Natoshia Askelson; Robin C Vanderpool; Lindsay Stradtman; Jean Edward; Paige E Farris; Victoria Petermann; Jan M Eberth Journal: Prev Med Date: 2019-08-15 Impact factor: 4.018
Authors: Shaila M Strayhorn; Leslie R Carnahan; Kristine Zimmermann; Theresa A Hastert; Karriem S Watson; Carol Estwing Ferrans; Yamilé Molina Journal: Support Care Cancer Date: 2019-07-24 Impact factor: 3.603
Authors: Salene M W Jones; Rebecca Ziebell; Rod Walker; Larissa Nekhlyudov; Borsika A Rabin; Stephanie Nutt; Monica Fujii; Jessica Chubak Journal: Support Care Cancer Date: 2016-12-15 Impact factor: 3.603
Authors: Shoshana Adler Jaffe; Dolores D Guest; Andrew L Sussman; Charles L Wiggins; Jessica Anderson; Jean A McDougall Journal: Cancer Causes Control Date: 2021-06-27 Impact factor: 2.506
Authors: Matthew P Banegas; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Stephanie Nutt; Loyce Pace; Alexandra Varga; Lisa Waiwaiole; Jennifer Schneider; K Robin Yabroff Journal: J Cancer Surviv Date: 2017-08-29 Impact factor: 4.442